Incyte to acquire Vega Therapeutics for $1.25 billion upfront
Incyte Corp. (NASDAQ: INCY) announced it has entered into a definitive agreement to acquire Vega Therapeutics, Inc., a wholly owned ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
